Infective pulmonary exacerbation of cystic fibrosis

DBCOND0014184Congenital, Hereditary, and Neonatal Diseases and Abnormalities Exocrine pancreas conditions

Infective pulmonary exacerbation of cystic fibrosis is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Exocrine pancreas conditions
Infections
Neonatal and Perinatal Conditions
Respiratory Tract Diseases
Indicated drugs: Amikacin

Resolves to

Vocabularies

MedDRA10070608UMLSC2938941

What you can answer from here — as of October 31, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for Infective pulmonary exacerbation of cystic fibrosis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account